Stocktoria
PROTHENA CORP PUBLIC LTD CO PRTA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-12-21
PROTHENA CORP PUBLIC LTD CO statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -2216.4% | -114.4% | -209.1% | -244.1% | 35.9% |
| Net margin | -2520.6% | -90.5% | -160.9% | -217.0% | 33.4% |
| Return on assets | -74.7% | -22.4% | -21.1% | -15.4% | 11.0% |
| Return on equity | -87.0% | -25.1% | -26.2% | -18.8% | 14.4% |
| Current ratio | 7.72 | 10.01 | 11.24 | 14.34 | 17.48 |
| Revenue growth | -92.8% | 47.9% | 69.5% | -73.1% | 23414.3% |
Source: SEC EDGAR filings · CIK 0001559053 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.